Journal Browser Advanced Search Help
Journal Browser Advanced search HELP
-
J Korean Surg Soc. 2000 Oct;59(4):458-462. Korean. Original Article.
Hwang SB , Han S , Suh HS , Kim SR , Kim HY .
Department of Surgery, Inje University Sanggye Paik Hospital, Seoul, Korea.
Department of Radiation Oncology, Inje University Sanggye Paik Hospital, Seoul, Korea.
Department of Internal Medicine, Inje University Sanggye Paik Hospital, Seoul, Korea.
Abstract

PURPOSE: Breast conserving surgery is increasingly performed in early stage breast cancer patients. A certain propotion of these patients are at substantial risk for systemic metastasis. However, there is no valid consensus about optimal sequencing of chemotherapy and radiation therapy. METHODS: We conducted a randomized prospective study to investigate whether concurrent chemotherapy and radiation therapy after breast conserving surgery are associated with increased toxicity. Fifty-seven patients with stage I or II breast cancer were randomly assigned to receive CMF chemotherpy either simultaneously with (n=37) or before (n=20) radiation therapy. RESULTS: Moist desquamation was the most common adverse effect which occurred in 46% (16/37) of the patients treated with concurrent chemotherapy and radiation therapy and 40% (8/20) of those treated with the sequential regimen. This difference between two groups was not statistically significant. Also the incidence of severe neutropenia (WBC<1,800) or abnormal elevation of liver enzymes was not influenced by the sequencing of the adjuvant therapies. Arm edema was observed in 2 patients of the concurrent group and in 2 patients of the sequential regimen. Two patients treated with the concurrent regimen did not complete 6 cycles of chemotherapy while only one patient treated with sequential regimen did not. The incidence of toxicity during chemotherapy was not altered by the timing of radiation therapy. CONCLUSION: Chemotherapy and radiation therapy can be given concurrently after breast conserving surgery in stage I or II breast cancer patients without increase in serious toxicity.

Copyright © 2019. Korean Association of Medical Journal Editors.